Gregory Scott Duncan - 26 Feb 2024 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Issuer symbol
DWTX
Transactions as of
26 Feb 2024
Net transactions value
$0
Form type
4
Filing time
28 Feb 2024, 12:40:36 UTC
Previous filing
18 Aug 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +138,835 $0.000000 138,835 26 Feb 2024 Common Stock 138,835 $0.3570 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on February 26, 2025, one year following the grant date.